Wolters Kluwer, NL0000395903

Wolters Kluwer stock to acquire AgileMD for up to $100 million

Published on 11/20/2026 at 17:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Wolters Kluwer stock draws attention after the company agreed to acquire AgileMD. The deal includes a $40 million upfront payment and performance-linked deferred consideration.

AgileMD strengthens clinical software

  • The transaction is expected to close in the first quarter of 2027 or sooner, subject to customary conditions and approvals.
  • AgileMD's annual recurring revenue is expected to reach $7 million by year-end 2026.
  • Wolters Kluwer expects an immaterial impact on adjusted earnings from the acquisition.
Wolters Kluwer, NL0000395903, Illustration mit AI erstellt.

Wolters Kluwer agreed on November 13, 2026, to acquire AgileMD, a healthcare technology company focused on AI-powered clinical decision support, for up to $100 million. The announcement was published by Euronext on behalf of Wolters Kluwer.

AgileMD expands clinical software

Wolters Kluwer Health will pay $40 million upfront, with the remaining consideration deferred and linked to performance targets. AgileMD provides interactive clinical pathways and predictive analytics for healthcare professionals, while its eCART product is an FDA-cleared clinical surveillance engine.

The acquisition is intended to extend UpToDate Expert AI into embedded workflows, local guidelines and other digital health applications. Wolters Kluwer said UpToDate Expert AI had reached more than 2,700 U.S. hospitals and health systems since its introduction in September 2025.

Deal terms and timing

AgileMD was founded in 2011 and is based in San Francisco. All 23 employees are expected to join Wolters Kluwer Health, and the business is expected to reach $7 million in annual recurring revenue by year-end 2026.

Wolters Kluwer expects the transaction to generate a return on invested capital at or above its after-tax weighted average cost of capital of 8% within three to five years. The company expects the effect on adjusted earnings to be immaterial. Closing is expected in the first quarter of 2027 or sooner, subject to customary closing conditions and governmental approvals.

Wolters Kluwer company facts

  • Company: Wolters Kluwer N.V.
  • ISIN: NL0000395903
  • Ticker: WKL
  • Listing: Euronext Amsterdam
  • Announcement date: November 13, 2026

The Dutch market backdrop is tracked through the AEX.

More news and analyses on Wolters Kluwer stock

Disclaimer...
en | NL0000395903 | WOLTERS KLUWER | boerse | 70540680 | bgmi